INVESTOR AB - Q2 2021 holdings

Add to watchlist

$3.41 Billion is the total value of INVESTOR AB's 3 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was - .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2021
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NASDAQ OMX GROUP INC45Q2 2024100.0%
AGILE THERAPEUTICS INC32Q1 20223.5%
CHINACACHE INTL HLDG LTD21Q2 20187.3%
MATTERSIGHT CORP21Q2 20182.0%
CORCEPT THERAPEUTICS INC18Q3 20171.8%
TANGOE INC16Q1 20174.0%
NEURONETICS INC11Q4 20203.3%
CONSTANT CONTACT INC11Q4 20150.7%
CARLYLE GROUP LP11Q1 20180.2%
STANLEY BLACK & DECKER, INC.10Q4 20230.0%

View INVESTOR AB's complete holdings history.

Latest significant ownerships (13-D/G)
INVESTOR AB Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ERICSSON LM TELEPHONE COMay 21, 2024170,982,9325.6%
NASDAQ, INC.November 06, 202358,182,42610.1%
ABB LTDJune 27, 2022265,385,14214.0%
ChinaCache International Holdings Ltd.Sold outFebruary 14, 201900.0%
AGILE THERAPEUTICS INCFebruary 17, 20153,510,18918.9%
GREENWAY MEDICAL TECHNOLOGIES INCSold outFebruary 14, 201400.0%
TANGOE INCFebruary 14, 20141,440,0003.8%
Mattersight CorpSold outMay 10, 201200.0%
ISTA PHARMACEUTICALS INCFebruary 14, 20111,258,0753.8%
ACHILLION PHARMACEUTICALS INCFebruary 11, 20111,980,1293.4%

View INVESTOR AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-08-14
SC 13D2024-05-21
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-11-06
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13D/A2022-12-16

View INVESTOR AB's complete filings history.

All filings

View complete filings history.

Compare quarters

Export INVESTOR AB's holdings

CSVXLS